Last update at 2025-06-13T17:59:00Z
Source: TradingView
The charts and visual representations are sourced from TradingView through embedded widgets. For any issues with chart display, please visit the TradingView website
Are Investors Undervaluing Chemring Group PLC (LON:CHG) By 40%?
Mon 05 May 25, 06:11 AMChemring Group (LON:CHG) Is Doing The Right Things To Multiply Its Share Price
Mon 14 Apr 25, 01:30 PMChemring Group (LON:CHG) Will Pay A Larger Dividend Than Last Year At £0.052
Tue 04 Mar 25, 12:40 PMFTSE-listed RAF supplier becomes target of £1bn US takeover
Mon 24 Feb 25, 03:36 PMChemring Group's (LON:CHG) Dividend Will Be Increased To £0.052
Tue 04 Feb 25, 01:00 PMChemring Group Full Year 2024 Earnings: Revenues Beat Expectations, EPS Lags
Fri 20 Dec 24, 06:28 AMIs Chemring Group PLC (LON:CHG) Trading At A 38% Discount?
Thu 07 Nov 24, 12:45 PMBreakdown | 2023-10-31 | 2022-10-31 | 2021-10-31 | 2020-10-31 | 2019-10-31 |
---|---|---|---|---|---|
Type | yearly | yearly | yearly | yearly | yearly |
Date | 2023-10-31 | 2022-10-31 | 2021-10-31 | 2020-10-31 | 2019-10-31 |
Income before tax | 44.10M | 51.80M | 48.80M | 43.30M | 26.70M |
Minority interest | - | - | - | - | - |
Net income | 5.40M | 47.40M | 41.50M | 34.70M | 21.90M |
Selling general administrative | - | - | - | - | 128.50M |
Selling and marketing expenses | - | - | - | - | - |
Gross profit | - | 442.80M | 393.30M | 402.50M | 335.20M |
Reconciled depreciation | 22.30M | 22.90M | 25.10M | 28.80M | 29.30M |
Ebit | - | 53.30M | 50.40M | 46.30M | 31.30M |
Ebitda | - | 76.20M | 75.50M | 75.10M | 60.60M |
Depreciation and amortization | - | 22.90M | 25.10M | 28.80M | 29.30M |
Non operating income net other | - | - | - | - | - |
Operating income | 45.40M | 53.30M | 50.40M | 46.30M | 31.30M |
Other operating expenses | - | -389.50000M | -342.90000M | -356.20000M | -303.90000M |
Interest expense | 1.30M | 1.50M | 1.60M | 3.00M | 4.60M |
Tax provision | 6.40M | 4.40M | 7.30M | 8.60M | 3.60M |
Interest income | - | - | - | - | 0.20M |
Net interest income | - | - | - | - | - |
Extraordinary items | - | - | - | - | - |
Non recurring | - | - | - | - | - |
Other items | - | - | - | - | - |
Income tax expense | - | 4.40M | 7.30M | 8.60M | 3.60M |
Total revenue | 472.60M | 442.80M | 393.30M | 402.50M | 335.20M |
Total operating expenses | - | -389.50000M | -342.90000M | -356.20000M | -303.90000M |
Cost of revenue | - | - | - | - | 92.50M |
Total other income expense net | - | -1.50000M | -1.60000M | -3.00000M | -4.60000M |
Discontinued operations | - | - | - | - | -1.20000M |
Net income from continuing ops | 37.70M | 47.40M | 41.50M | 34.70M | 23.10M |
Net income applicable to common shares | - | 47.40M | 41.50M | 34.70M | 21.90M |
Preferred stock and other adjustments | - | - | - | - | - |
Breakdown | 2023-10-31 | 2022-10-31 | 2021-10-31 | 2020-10-31 | 2019-10-31 |
---|---|---|---|---|---|
Type | yearly | yearly | yearly | yearly | yearly |
Date | 2023-10-31 | 2022-10-31 | 2021-10-31 | 2020-10-31 | 2019-10-31 |
Total assets | 596.40M | 620.10M | 531.50M | 541.40M | 498.30M |
Intangible assets | 27.20M | 46.00M | 44.10M | 46.40M | 51.40M |
Earning assets | - | - | - | - | - |
Other current assets | - | 2.40M | 1.50M | 0.60M | 11.60M |
Total liab | 217.90M | 202.00M | 178.70M | 211.80M | 192.50M |
Total stockholder equity | 378.50M | 418.10M | 352.80M | 329.60M | 305.80M |
Deferred long term liab | - | 34.60M | 30.00M | 29.80M | 26.10M |
Other current liab | - | 13.70M | 15.00M | 13.10M | 11.50M |
Common stock | - | 2.80M | 2.80M | 2.80M | 2.80M |
Capital stock | 2.80M | 2.80M | 2.80M | 2.80M | 2.80M |
Retained earnings | 62.90M | 87.20M | 56.20M | 28.00M | 8.50M |
Other liab | - | 63.10M | 45.60M | 38.60M | 35.70M |
Good will | 100.50M | 118.10M | 108.70M | 108.50M | 108.50M |
Other assets | - | 78.10M | 61.90M | 53.10M | 54.20M |
Cash | 6.40M | 19.80M | 5.80M | 14.70M | 1.30M |
Cash and equivalents | - | - | - | - | - |
Total current liabilities | 142.10M | 113.70M | 102.50M | 111.80M | 149.00M |
Current deferred revenue | - | - | - | - | - |
Net debt | 7.70M | 7.10M | 26.50M | 48.10M | 75.60M |
Short term debt | - | 1.80M | 1.80M | 1.50M | 69.20M |
Short long term debt | - | 0.00000M | 0.40M | 0.00000M | 69.20M |
Short long term debt total | - | 26.90M | 32.30M | 62.80M | 76.90M |
Other stockholder equity | - | 328.10M | 293.80M | 298.80M | 294.50M |
Property plant equipment | - | 231.30M | 198.70M | 194.00M | 170.00M |
Total current assets | 183.70M | 181.20M | 148.10M | 169.20M | 140.30M |
Long term investments | - | - | - | - | - |
Net tangible assets | - | 288.60M | 230.00M | 204.50M | 172.00M |
Short term investments | - | - | - | - | - |
Net receivables | 74.80M | 61.10M | 54.60M | 58.60M | 45.60M |
Long term debt | 14.10M | 20.90M | 28.10M | 57.50M | 7.80M |
Inventory | 101.70M | 99.60M | 80.70M | 91.30M | 78.10M |
Accounts payable | 124.00M | 98.20M | 85.70M | 97.20M | 68.30M |
Total permanent equity | - | - | - | - | - |
Noncontrolling interest in consolidated entity | - | - | - | - | - |
Temporary equity redeemable noncontrolling interests | - | - | - | - | - |
Accumulated other comprehensive income | - | - | - | - | - |
Additional paid in capital | - | - | - | - | - |
Common stock total equity | - | - | - | - | - |
Preferred stock total equity | - | - | - | - | - |
Retained earnings total equity | - | - | - | - | - |
Treasury stock | - | - | - | - | - |
Accumulated amortization | - | - | - | - | - |
Non currrent assets other | - | 11.20M | 13.70M | 7.60M | 9.60M |
Deferred long term asset charges | - | - | - | - | - |
Non current assets total | 412.70M | 438.90M | 383.40M | 372.20M | 358.00M |
Capital lease obligations | 6.60M | 6.00M | 3.80M | 5.30M | - |
Long term debt total | - | - | - | - | - |
Breakdown | 2023-10-31 | 2022-10-31 | 2021-10-31 | 2020-10-31 | 2019-10-31 |
---|---|---|---|---|---|
Type | yearly | yearly | yearly | yearly | yearly |
Date | 2023-10-31 | 2022-10-31 | 2021-10-31 | 2020-10-31 | 2019-10-31 |
Investments | -39.40000M | -30.50000M | -34.90000M | -25.40000M | -41.70000M |
Change to liabilities | - | 2.90M | -10.30000M | 25.20M | -2.70000M |
Total cashflows from investing activities | - | -30.50000M | -34.90000M | -25.40000M | -41.70000M |
Net borrowings | - | -13.20000M | -28.10000M | -16.80000M | -18.10000M |
Total cash from financing activities | -40.20000M | -35.80000M | -50.40000M | -32.10000M | -32.80000M |
Change to operating activities | - | 0.10M | -0.30000M | 0.40M | -0.30000M |
Net income | 45.40M | 53.30M | 50.40M | 46.30M | 31.30M |
Change in cash | -13.40000M | 14.40M | -9.30000M | 18.00M | -12.90000M |
Begin period cash flow | 19.80M | 5.40M | 14.70M | -3.30000M | 9.60M |
End period cash flow | 6.40M | 19.80M | 5.40M | 14.70M | -3.30000M |
Total cash from operating activities | 65.90M | 80.50M | 75.70M | 75.90M | 61.90M |
Issuance of capital stock | 0.60M | 0.10M | 0.40M | 0.50M | - |
Depreciation | 22.30M | 22.90M | 25.10M | 28.80M | 29.30M |
Other cashflows from investing activities | - | -2.00000M | -2.00000M | 0.90M | 2.40M |
Dividends paid | 17.30M | 14.40M | 11.90M | 10.40M | 9.50M |
Change to inventory | -18.20000M | -6.40000M | 7.90M | -12.20000M | -7.90000M |
Change to account receivables | -18.70000M | 4.50M | 0.90M | -9.90000M | 10.40M |
Sale purchase of stock | -14.00000M | -7.00000M | -7.10000M | -2.40000M | - |
Other cashflows from financing activities | 114.60M | 53.00M | 47.80M | 206.60M | -5.20000M |
Change to netincome | - | 9.10M | 10.90M | 8.90M | 11.20M |
Capital expenditures | 34.20M | 34.50M | 30.20M | 40.80M | 44.80M |
Change receivables | - | - | - | - | - |
Cash flows other operating | - | - | - | - | - |
Exchange rate changes | - | - | - | - | - |
Cash and cash equivalents changes | - | - | - | - | - |
Change in working capital | -12.90000M | 1.10M | -1.80000M | 3.50M | -0.50000M |
Stock based compensation | 4.40M | 6.40M | 5.30M | 4.00M | 2.50M |
Other non cash items | 6.70M | -3.20000M | -3.30000M | -6.70000M | -4.70000M |
Free cash flow | 31.70M | 46.00M | 45.50M | 35.10M | 17.10M |
Sector: Industrials Industry: Aerospace & Defense
Company | Change (USD) | Price (USD) | Trailing PE (x) | Forward PE (x) | Price Sales TTM (x) | Price to Book Value (x) | Enterprise Value to Revenue (x) | Enterprise Value to EBITDA (x) |
---|---|---|---|---|---|---|---|---|
CMGMY Chemring Group PLC ADR |
0.02 0.25% | 7.97 | 33.14 | 14.08 | 2.57 | 2.81 | 2.16 | 16.86 |
BA The Boeing Company |
3.29 1.64% | 203.61 | - | 294.12 | 1.68 | - | 2.25 | 111.56 |
EADSY Airbus Group NV |
0.76 1.65% | 46.87 | 27.76 | 21.51 | 1.93 | 7.21 | 1.79 | 13.93 |
EADSF Airbus Group SE |
3.70 2.01% | 188.11 | 27.24 | 21.28 | 1.91 | 7.14 | 1.79 | 13.93 |
RTX Raytheon Technologies Corp |
0.49 0.34% | 146.18 | 38.65 | 15.77 | 1.77 | 1.69 | 2.22 | 16.02 |
Chemring Group PLC provides countermeasures, sensors, information, and energetic products in the United States, the United Kingdom, Europe, the Asia pacific, and internationally. The company offers sensors and information products, such as point chemical detector, sensor, JSLSCAD, and I-SCAD; miniature radar altimeter, R Visor, 3D radars, husky mounted detection system, groundshark, MDS-10, and groundhunters; resolve, locate, LOCATE-T, and viper products; and advisory, research, and design and engineering services. It also provides countermeasures and energetics products, including aerodynamic and kinematic flare; chaf cart and pack; seduction and distraction cart; initiator, separation and explosive bolts, nuts, and pin pullers and pushers; initiators, actuators, retractors and systems, time delay devices, ejection handles and sequencers, gas generators, cutters, canopy remover thruster, and thermal battery; wing, fin, elevon deployment actuators, wing and tail retention systems, separation nuts, pyrovalves, and safe and arm devices; joint combined aircrew system, system communication and oxygen, and altitude combined aircrew system tester; HMX, RDX, NTO, Alkyl-NENA, and acetic acid; and advanced performance bangalore torpedo, SX4, PE8, charge demolition user filled conical and linear, igniter safety fuze electric, detonating cord booster, demolition detonator electric and non-electric, detonating cord, and safety fuze. In addition, the company offers metron actuators and gas generators; igniters and fuzeheads, and canopy severance cords and explosive transmission cords; extruded double base propellant for ejection systems and rocket motors; and PED MK 2, breach MC, shrike exploder, mini shrike, long range initiation system, WASP, pigstick, hotrod, mini and midi disruptor, freeze neutralizing kit, fuse extractor, and rocket wrench. Chemring Group PLC was incorporated in 1905 and is headquartered in Romsey, the United Kingdom.
Roke Manor, Romsey, United Kingdom, SO51 0ZN
Name | Title | Year Born |
---|---|---|
Mr. Michael Ord | Group Chief Exec. & Director | NA |
Mr. Andrew G. Lewis | CFO & Director | 1971 |
Ms. Sarah L. Ellard FCIS | Group Legal Director, Company Sec. & Exec. Director | 1971 |
Mr. Llyr Jones | Group Strategy & Corp. Devel. Director | NA |
Ms. Clancy Murphy | Chief People Officer | NA |
Mr. Paul MacGregor | Managing Director of Roke | NA |
Mr. Bill Currer | Pres of CHG Group, Inc. | NA |
Simon Darling | Managing Director of Chemring Countermeasures - UK | NA |
Dan Reinke | Acting Group HSE Director | NA |
Mr. Michael Ord | Group Chief Executive & Director | 1967 |
Disclaimer - This information, including any data, is sourced from Unicorn Data Services SAS, trading as EOD Historical Data (“EODHD”) on ‘as is’ basis, using their API. The information and data provided on this page, as well as via the API, are not guaranteed to be real-time or accurate. In some cases, the data may include analyst ratings or recommendations sourced through the EODHD API, which are intended solely for general informational purposes. This information does not consider your personal objectives, financial situation, or needs. Kalkine does not assume any responsibility for any trading losses you might incur as a result of using this information, data, or any analyst rating or recommendation provided. Kalkine will not accept any liability for any loss or damage resulting from reliance on the information, including but not limited to data, quotes, charts, analyst ratings, recommendations, and buy/sell signals sourced via the API. Please be fully informed about the risks and costs associated with trading in the financial markets, as it is one of the riskiest forms of investment. Kalkine does not provide any warranties regarding the information on this page, including, without limitation, warranties of merchantability or fitness for a particular purpose or use.